Springer Nature
Browse
13148_2019_742_MOESM8_ESM.docx (16.76 kB)

MOESM8 of Epigenetic silencing of MEIS2 in prostate cancer recurrence

Download (16.76 kB)
journal contribution
posted on 2019-10-23, 08:27 authored by Maibritt Nørgaard, Christa Haldrup, Marianne Bjerre, Søren Høyer, Benedicte Ulhøi, Michael Borre, Karina Sørensen
Additional file 8: Table S5. Uni- and multivariate cox regression of MEIS2 RNA expression in the TCGA RNAseq cohort. BCR was used as end-point (n=389 patients). Cont.: continuous. Path.: Pathologic. HR: Hazard ratio. CI: Confidence interval. BCR, biochemical recurrence.

Funding

Kræftens Bekæmpelse

History

Usage metrics

    Clinical Epigenetics

    Categories

    Keywords

    Prostate cancerDNA methylationRNA expressionMEIS2Epigenetic silencingBiomarkerPrognosis

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC